• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一位药物基因组学、联合用药患者的转换障碍:病例报告

Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report.

作者信息

Schuh Michael J, Crosby Sheena

机构信息

Mayo Clinic, Jacksonville, Florida.

出版信息

Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4034. eCollection 2021.

DOI:10.24926/iip.v12i4.4034
PMID:36033110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9401363/
Abstract

Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.

摘要

转换障碍(CD)是一种相对常见的精神疾病,临床药师可能会遇到,但可能不容易被药师识别。这是一个病例,一名震颤患者被转诊至由药师主导的多药治疗、药物基因组学(PGx)服务,以排除因药物代谢导致的PGx病因。未发现震颤的药理学或PGx病因,这有助于支持和确诊转换障碍。通过与精神科医生、神经科医生、物理医学同事合作,临床药师可以通过协助诊断和适当治疗为患者护理增添价值。

相似文献

1
Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report.一位药物基因组学、联合用药患者的转换障碍:病例报告
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4034. eCollection 2021.
2
Chronic Anticholinergic Toxicity Discovered in a Pharmacogenomics, Polypharmacy Patient.在一名药物基因组学、联合用药患者中发现慢性抗胆碱能毒性。
Sr Care Pharm. 2021 Jun 1;36(6):304-310. doi: 10.4140/TCP.n.2021.304.
3
Description of an Established, Fee-for-Service, Office-Based, Pharmacist-Managed Pharmacogenomics Practice.一项已确立的、按服务收费的、基于办公室的、由药剂师管理的药物基因组学实践的描述。
Sr Care Pharm. 2019 Dec 1;34(10):660-668. doi: 10.4140/TCP.n.2019.660.
4
Implementing a Pharmacist-Led Primary Care Pharmacogenomics Medication Management Service.实施由药剂师主导的基层医疗药物基因组学药物管理服务。
Innov Pharm. 2024 May 31;15(2). doi: 10.24926/iip.v15i2.6178. eCollection 2024.
5
Applications for pharmacogenomics in pharmacy practice: A scoping review.药学实践中药物基因组学的应用:范围综述。
Res Social Adm Pharm. 2022 Jul;18(7):3094-3118. doi: 10.1016/j.sapharm.2021.08.009. Epub 2021 Aug 20.
6
Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).为老年人全包式护理计划(PHARM-GENOME-PACE)实施由药剂师主导的药物基因组学服务。
J Am Pharm Assoc (2003). 2018 May-Jun;58(3):281-289.e1. doi: 10.1016/j.japh.2018.02.011. Epub 2018 Mar 27.
7
Implementation of a pharmacist-provided pharmacogenomics service in an executive health program.在高管健康计划中实施药师提供的药物基因组学服务。
Am J Health Syst Pharm. 2021 Jun 7;78(12):1094-1103. doi: 10.1093/ajhp/zxab137.
8
Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.支持药物基因组学报告解读的药剂师咨询报告
Pharmgenomics Pers Med. 2020 Dec 10;13:719-724. doi: 10.2147/PGPM.S276687. eCollection 2020.
9
Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.患者对药师提供的临床药物基因组学服务的看法。
Pharmacogenomics. 2022 Jun;23(8):463-474. doi: 10.2217/pgs-2022-0013. Epub 2022 Apr 26.
10
Polypharmacy as Formal Training and a Model of Practice.药物滥用作为正式培训和实践模式。
Sr Care Pharm. 2024 May 1;39(5):173-177. doi: 10.4140/TCP.n.2024.173.

本文引用的文献

1
Polypharmacy among children and adolescents with psychiatric disorders in a mental referral hospital in Botswana.博茨瓦纳一家精神专科医院中患有精神疾病的儿童和青少年的多重用药情况。
BMC Psychiatry. 2017 May 10;17(1):174. doi: 10.1186/s12888-017-1347-6.
2
Does association of opioid use with pain and function differ by fibromyalgia or widespread pain status?阿片类药物的使用与疼痛及功能之间的关联在纤维肌痛或广泛性疼痛状态方面是否存在差异?
Pain. 2016 Oct;157(10):2208-2216. doi: 10.1097/j.pain.0000000000000631.
3
Conversion Disorder- Mind versus Body: A Review.转换障碍——身心关系:综述
Innov Clin Neurosci. 2015 May-Jun;12(5-6):27-33.
4
Functional (conversion) neurological symptoms: research since the millennium.功能性(转换性)神经系统症状:千禧年后的研究。
J Neurol Neurosurg Psychiatry. 2012 Aug;83(8):842-50. doi: 10.1136/jnnp-2011-301860. Epub 2012 Jun 3.
5
A Bayesian account of 'hysteria'.关于“癔症”的贝叶斯解释。
Brain. 2012 Nov;135(Pt 11):3495-512. doi: 10.1093/brain/aws129. Epub 2012 May 28.
6
Issues for DSM-5: Conversion disorder.《精神疾病诊断与统计手册》第五版相关问题:转换障碍
Am J Psychiatry. 2010 Jun;167(6):626-7. doi: 10.1176/appi.ajp.2010.09101440.
7
Non-epileptic seizures and child sexual abuse: a critical review of the literature.
Clin Psychol Rev. 2006 Dec;26(8):1020-40. doi: 10.1016/j.cpr.2005.11.011. Epub 2006 Feb 10.
8
Systematic review of misdiagnosis of conversion symptoms and "hysteria".转换症状和“癔症”误诊的系统评价
BMJ. 2005 Oct 29;331(7523):989. doi: 10.1136/bmj.38628.466898.55. Epub 2005 Oct 13.
9
Functional symptoms in neurology: management.神经病学中的功能性症状:管理
J Neurol Neurosurg Psychiatry. 2005 Mar;76 Suppl 1(Suppl 1):i13-21. doi: 10.1136/jnnp.2004.061663.
10
Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics.运动转换症状与假性癫痫:临床特征比较
Psychosomatics. 2004 Nov-Dec;45(6):492-9. doi: 10.1176/appi.psy.45.6.492.